Just minutes and hours after the US Supreme Court issued its much-anticipated decision regarding the constitutionality of The Patient Protection and Affordable Care Act (PPACA or ACA) on June 28th, commentators in all walks of life scrambled to offer their insights via various media outlets. Our McGuireWoods colleagues also prepared a thoughtful analysis of the decision and its implications on various sectors in this publication. Clearly, the decision and the ongoing Congressional and state-level battles over healthcare reform will continue to impact long-time and newer investors in healthcare and life sciences.